EU agreed 15.50 euros per dose for Pfizer vaccine

 

The cost, which is confidential & was negotiated for a total of 300 million doses, is slightly lower than the $19.50 a picture the United States agreed to pay for a very first shipment of hundred million doses of the identical vaccine, in line with what Reuters reported in November.

The EU document dated Nov. 18 was circulated internally following the EU announced its supply package with Pfizer and the German partner BioNTech of its on Nov. 11.

The EU drug regulator is actually anticipated to determine on Monday on approval for the Pfizer vaccine after the shot was authorised in several countries, including Britain and the United States.

On Thursday Belgian say secretary for the spending budget Eva De Bleeker released on Twitter a dining room table with price tags Belgium would pay pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the content shortly after posting.

In that dining room table the Pfizer vaccine was indicated as costing Belgium twelve euros ($14.6) per dose, top many to think this was the entire fee agreed by way of the EU.

Other vaccines in the table were also shown with prices lower than prices disclosed by EU sources.

“There is , obviously , a complete fee and a price upon delivery,” an EU official involved in talks with vaccine creators told Reuters when directed to clarify the difference between the Belgian and EU rates.

A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In this public hearing, De Beeker said Belgium’s budgeted costs were still partial.

Underneath EU advance purchase deals for COVID-19 vaccines, the bloc believes upfront payments with businesses to secure doses before they are approved. Following approvals, EU governments can pay the remainder to buy reserved doses.

The EU has not revealed the upfront payment agreed with Pfizer.

Nevertheless, it said in October that it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson & Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for initial payments to Pfizer BioNTech, Moderna and Curevac.

It’s since agreed source deals with all six corporations and it is negotiating a seventh understanding with Novavax.